Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab

INTRODUCTION: The advent of pembrolizumab has contributed to improved treatment outcomes for metastatic urothelial carcinoma, but the outcomes of treatments after second‐line treatment have not been established. CASE PRESENTATION: A 72‐year‐old man was referred to our hospital with gross hematuria a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Takayuki, Takeuchi, Nobuyoshi, Sazuka, Tomokazu, Sato, Hiroaki, Imamura, Yusuke, Sakamoto, Shinichi, Komiya, Akira, Ichikawa, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560445/
https://www.ncbi.nlm.nih.gov/pubmed/34755056
http://dx.doi.org/10.1002/iju5.12348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560445/
https://www.ncbi.nlm.nih.gov/pubmed/34755056
http://dx.doi.org/10.1002/iju5.12348

Ejemplares similares